HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.

Michael J Ombrello; Elaine F Remmers; Ioanna Tachmazidou; Alexei Grom; Dirk Foell; Johannes-Peter Haas; Alberto Martini; Marco Gattorno; Seza Özen; Sampath Prahalad; +46 more... Andrew S Zeft; John F Bohnsack; Elizabeth D Mellins; Norman T Ilowite; Ricardo Russo; Claudio Len; Maria Odete E Hilario; Sheila Oliveira; Rae SM Yeung; Alan Rosenberg; Lucy R Wedderburn; Jordi Anton; Tobias Schwarz; Anne Hinks; Yelda Bilginer; Jane Park; Joanna Cobb; Colleen L Satorius; Buhm Han; Elizabeth Baskin; Sara Signa; Richard H Duerr; JP Achkar; M Ilyas Kamboh; Kenneth M Kaufman; Leah C Kottyan; Dalila Pinto; Stephen W Scherer; Marta E Alarcón-Riquelme; Elisa Docampo; Xavier Estivill; Ahmet Gül; British Society of Pediatric and Adolescent Rheumatology (BSPAR); Childhood Arthritis Prospective Study (CAPS) Group; Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) I; Sparks-Childhood Arthritis Response to Medication Study (CHARMS); Biologically Based Outcome Predictors in JIA (BBOP) Group; Paul IW de Bakker; Soumya Raychaudhuri; Carl D Langefeld; Susan Thompson; Eleftheria Zeggini; Wendy Thomson; Daniel L Kastner; Patricia Woo; International Childhood Arthritis Genetics (INCHARGE) Consortium; (2015) HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proceedings of the National Academy of Sciences of the United States of America, 112 (52). pp. 15970-15975. ISSN 0027-8424 DOI: 10.1073/pnas.1520779112
Copy

Systemic juvenile idiopathic arthritis (sJIA) is an often severe, potentially life-threatening childhood inflammatory disease, the pathophysiology of which is poorly understood. To determine whether genetic variation within the MHC locus on chromosome 6 influences sJIA susceptibility, we performed an association study of 982 children with sJIA and 8,010 healthy control subjects from nine countries. Using meta-analysis of directly observed and imputed SNP genotypes and imputed classic HLA types, we identified the MHC locus as a bona fide susceptibility locus with effects on sJIA risk that transcended geographically defined strata. The strongest sJIA-associated SNP, rs151043342 [P = 2.8 × 10(-17), odds ratio (OR) 2.6 (2.1, 3.3)], was part of a cluster of 482 sJIA-associated SNPs that spanned a 400-kb region and included the class II HLA region. Conditional analysis controlling for the effect of rs151043342 found that rs12722051 independently influenced sJIA risk [P = 1.0 × 10(-5), OR 0.7 (0.6, 0.8)]. Meta-analysis of imputed classic HLA-type associations in six study populations of Western European ancestry revealed that HLA-DRB1*11 and its defining amino acid residue, glutamate 58, were strongly associated with sJIA [P = 2.7 × 10(-16), OR 2.3 (1.9, 2.8)], as was the HLA-DRB1*11-HLA-DQA1*05-HLA-DQB1*03 haplotype [6.4 × 10(-17), OR 2.3 (1.9, 2.9)]. By examining the MHC locus in the largest collection of sJIA patients assembled to date, this study solidifies the relationship between the class II HLA region and sJIA, implicating adaptive immune molecules in the pathogenesis of sJIA.

Full text not available from this repository.

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads